Q2 2021 Geron Corp Earnings Call Transcript
Ladies and gentlemen, thank you for standing by, and welcome to the Q2 2021 Geron Earnings Conference Call. (Operator Instructions) As a reminder, this conference call is being recorded.
I would now like to turn the conference over to your host, Ms. Olivia Bloom. Please go ahead.
All right. Thank you very much, Grace, and good afternoon, everyone. Welcome to this conference call to discuss updates on our ongoing imetelstat Phase III clinical trials as well as second quarter financial results.
I am joined today by Dr. John Scarlett, Geron's Chairman and Chief Executive Officer; Dr. Aleksandra Rizo, Geron's Executive Vice President and Chief Medical Officer; and Anil Kapur, Geron's Executive Vice President of Corporate Strategy and Chief Commercial Officer.
After the market closed today, we announced updates on our IMerge Phase III clinical trial and financial results for our second quarter via press release, which is available on our website. In
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |